Edited by James Harrison, Kunal Kulkarni, Mohamed Baguneid and Bernard Prendergast

in Oxford Handbook of Key Clinical Evidence

Published on behalf of Oxford University Press

Published in print November 2009 | ISBN: 9780199234073
Published online August 2010 | e-ISBN: 9780199598830 | DOI:

Series: Oxford Medical Handbooks


More Like This

Show all results sharing this subject:

  • Medical Statistics and Methodology


Show Summary Details


Introduction - Antiretroviral treatmentBoosted vs unboosted protease inhibitors - Initial treatment: number of nucleoside agents - Nucleoside reverse transcriptase inhibitor: optimal agents - Continuous vs intermittent antiretrovirals - Hepatitis C co-infectionHIV and hepatitis C co-infection - Cardiovascular riskAntiretroviral therapy and cardiovascular risk

Chapter.  3735 words. 

Subjects: Medical Statistics and Methodology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.